Martin Raw

Martin Raw

Auto-generated profile, based on publicly available information

Martin Raw

School of Global Public Health New York University New York NY USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2017 in Addiction
Verified
Journal Article
Open access
PDF file
KNKapka Nilan
Kapka Nilan
MRMartin Raw
Martin Raw
TMTricia M. McKeever
Tricia M. McKeever
RMRachael Murray
Rachael Murray
AMAnn Mcneill
Ann Mcneill
Aims: To (1) estimate the number of Parties to the Framework Convention on Tobacco Control (FCTC) providing tobacco dependence treatment in accordance with the recommendations of Article 14 and its guidelines; (2) assess association between provision and countries’ income level; and (3) assess progress over time. Design: Cross‐sectional study. Setting: Online survey from December 2014 to July 2015. Participants: Contacts in 172 countries were surveyed, representing 169 of the 180 FCTC Parties at the time of the survey. Measurements: A 26‐item questionnaire based on the Article 14 recommendations including tobacco treatment infrastructure and cessation support systems. Progress over time was assessed for those countries that also participated in our 2012 survey and did not change country income level classification. Findings: We received responses from contacts in 142 countries, an 83% response rate. Overall, 54% of respondents reported that their country had an officially identified person responsible for tobacco dependence treatment, 32% an official national treatment strategy, 40% official national treatment guidelines, 25% a clearly identified budget for treatment, 17% text messaging, 23% free national quitlines and 26% specialized treatment services. Most measures were associated positively and significantly with countries’ income level ( P < 0.001). Measures not associated significantly with income level included mandatory recording of tobacco use (30% of countries), offering help to health‐care workers (HCW) to stop using tobacco (44%), brief advice integrated into existing services (44%), and training HCW to give brief advice (81%). Reporting having an officially identified person responsible for tobacco cessation was the only measure with a statistically significant improvement over time ( P = 0.0351). Conclusion: Fewer than half of countries that are Parties to the Framework Convention on Tobacco Control have implemented the recommendations of Article 14 and its guidelines, and for most measures, provision was greater the higher the country's income. There was little improvement in treatment provision between 2012 and 2015 in all countries.

15 January 2009 in Addiction
Verified
Journal Article
Open access
PDF file
MRMartin Raw
Martin Raw
SRSusan Regan
Susan Regan
NRNancy A. Rigotti
Nancy A. Rigotti
AMAnn Mcneill
Ann Mcneill
Aims  This paper reports the results of a survey of national tobacco dependence treatment services in 36 countries. The objective was to describe the services and discuss the results in the context of Article 14 of the Framework Convention on Tobacco Control, which asks countries to promote adequate treatment for tobacco dependence.Design, setting and participants  A questionnaire on tobacco dependence treatment services was e‐mailed to a convenience sample of contacts in 2007. Completed questionnaires were received from contacts in 36 countries.Measurements  The survey instrument was a 10‐item questionnaire asking about treatment policy and practice, including medications.Findings  According to our informants, fewer than half the countries in our survey had an official written policy on (44%), or a government official responsible for (49%), treatment. Only 19% had a specialized national treatment system and only 24% said help was easily available in general practice. Most countries (94%) allowed the sale of nicotine replacement therapy (NRT), bupropion (75%) and varenicline (69%) but only 40% permitted NRT on ‘general sale’. Very few countries responding to the question fully reimbursed any of the medications. Fewer than half (45%) fully reimbursed brief advice and only 29% fully reimbursed intensive specialist support. Only 31% of countries said that their official treatment policy included the mandatory recording of patients' smoking status in medical notes.Conclusion  Taken together, our findings show that few countries have well‐developed tobacco dependence treatment services and that, at a national level, treatment is not yet a priority in most countries.

4 June 2009 in Addiction
Verified
Journal Article
Open access
PDF file
MRMartin Raw
Martin Raw
SRSusan Regan
Susan Regan
NRNancy A. Rigotti
Nancy A. Rigotti
AMAnn Mcneill
Ann Mcneill
Aims The Framework Convention on Tobacco Control (FCTC) asks countries to develop and disseminate comprehensive evidence‐based guidelines and promote adequate treatment for tobacco dependence, yet to date no summary of the content of existing guidelines exists. This paper describes the national tobacco dependence treatment guidelines of 31 countries. Design, setting, participants A questionnaire on tobacco dependence treatment guidelines was sent by e‐mail to a convenience sample of contacts working in tobacco control in 31 countries in 2007. Completed questionnaires were received from respondents in all 31 countries. During the course of these enquiries we also made contact with people in 14 countries that did not have treatment guidelines and sent them a short questionnaire asking about their plans to produce guidelines. Measurements The survey instrument was a 17‐item questionnaire asking the following key questions: do the guidelines recommend brief interventions, intensive behavioural support, medications; which medications; do the guidelines apply to the whole health‐care system and all professionals; do they refer explicitly to the Cochrane database; are they based on another country's guidelines; are they national or more local; are they endorsed formally by government; did they undergo peer review; who funded them; where were they published; do they include evidence on cost effectiveness of treatment? Findings According to respondents, all their countries' guidelines recommended brief advice, intensive behavioural support and nicotine replacement therapy (NRT); 84% recommended bupropion; 19% recommended varenicline; and 35% recommended telephone quitlines. Nearly half (48%) included cost‐effectiveness evidence. Seventy‐one per cent were supported formally by their government and 65% were supported financially by the government. Most (84%) used the Cochrane reviews as a source of evidence, 84% underwent a peer review process and 55% were based on the guidelines of other countries, most often the United States and England. Conclusion Overall, the guidelines reviewed followed the evidence base closely, recommending brief interventions, intensive behavioural support and NRT, and most recommended bupropion. Varenicline was not on the market in most of the countries in this survey when their guidelines were written, illustrating the need for guidelines to be updated periodically. None recommended interventions not proven to be effective, and some recommended explicitly against specific interventions (for lack of evidence). Most were peer‐reviewed, many through lengthy and rigorous procedures, and most were endorsed or supported formally by their governments. Some countries that did not have guidelines expressed a need for technical support, emphasizing the need for countries to share experience, something the FCTC process is well placed to support.

20 January 2016 in The Lancet
Verified
Journal Article
Closed access
PDF file
MRMartin Raw
Martin Raw
JMJudith Mackay
Judith Mackay
SRSrinath Reddy
Srinath Reddy


8 April 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AGAnalice Gigliotti
Analice Gigliotti
VFValeska C Figueiredo
Valeska C Figueiredo
CMClarice S Madruga
Clarice S Madruga
AMAna Cpr Marques
Ana Cpr Marques
IPIlana Pinsky
Ilana Pinsky
RLRonaldo Ramos Laranjeira
Ronaldo Ramos Laranjeira
Despite being the third largest tobacco producer in the world, Brazil has developed a comprehensive tobacco control policy that includes a broad restriction on both advertising and smoking in indoor public places, compulsory pictorial warning labels, and a menthol cigarette ban. However, tax and pricing policies have been developed slowly and only very recently were stronger measures implemented. This study investigated the expected responses of smokers to hypothetical price increases in Brazil.